Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists

Latest ABG-WTT Global Life Science Capital Partners GP Lt Stock Portfolio

$51.31Million

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About ABG-WTT Global Life Science Capital Partners GP Lt and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ABG-WTT Global Life Science Capital Partners GP Ltd reported an equity portfolio of $20.8 Millions as of 30 Sep, 2023.

The top stock holdings of ABG-WTT Global Life Science Capital Partners GP Ltd are , MDVL, RPID. The fund has invested 83% of it's portfolio in RAYZEBIO INC and 8.7% of portfolio in MEDAVAIL HOLDINGS INC.

They significantly reduced their stock positions in MEDAVAIL HOLDINGS INC (MDVL). ABG-WTT Global Life Science Capital Partners GP Ltd opened new stock positions in RAYZEBIO INC.

New Buys

Ticker$ Bought
MEDAVAIL HOLDINGS1,349,640

New stocks bought by ABG-WTT Global Life Science Capital Partners GP Lt

Additions

No additions were made to existing positions by ABG-WTT Global Life Science Capital Partners GP Lt

Reductions

None of the existing positions were reduced by ABG-WTT Global Life Science Capital Partners GP Lt

Sold off

Ticker$ Sold
MEDAVAIL HOLDINGS INC-1,803,530

ABG-WTT Global Life Science Capital Partners GP Lt got rid off the above stocks

Current Stock Holdings of ABG-WTT Global Life Science Capital Partners GP Lt

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
LUNGPULMONX CORP1.5060,204767,601UNCHANGED0.00
MDVLMEDAVAIL HOLDINGS2.63300,5881,349,640NEW
MDVLMEDAVAIL HOLDINGS INC0.000.000.00SOLD OFF-100
RPIDRAPID MICRO BIOSYSTEMS INC1.501,038,300768,339UNCHANGED0.00
RAYZEBIO INC94.38778,92248,425,600UNCHANGED0.00